Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Blood Transfusion Diagnostics Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for blood transfusion diagnostics has experienced a swift expansion in the past few years. The market is projected to rise from $4.42 billion in 2024 to $4.96 billion in 2025, with a compound annual growth rate (CAGR) of 12.2%. Reasons for this growth during the historic period include an upsurge in blood transfusions, the advent of new pathogens, an aging demographic, escalated demand for fast blood transfusion diagnostics, a climbing prevalence of chronic illnesses, and an increased demand for blood.

What Is the Forecast for the Blood Transfusion Diagnostics Market Size Through 2029?

We are anticipating a robust surge in the blood transfusion diagnostics market over the upcoming years, estimating a valuation of $6.43 billion by 2029, upholding a compound annual growth rate (CAGR) of 6.7%. This growth within the predicted period is seen as a result of the increasing need for precision medicine, substantial investment in blood transfusion facilities, rising demand for molecular blood transfusions, and new emerging infectious diseases, coupled with concerns related to blood safety. The forecast period also foresees significant trends such as advancements in diagnostic procedures, point-of-care testing, implementation of automation and robotics, the application of nucleic acid testing (NAT), digital integration, extension of pathogen panels, and the advent of advanced testing technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

What are the Key Market Players in Blood Transfusion Diagnostics Market and How They’re Evolving?

Major companies operating in the blood transfusion diagnostics market include BAG Health Care GmbH, Grifols S.A., Bio-Rad LaboratoriesInc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Novartis AG, F. Hoffmann-La Roche Ltd., bioMerieux, Diagast SAS, Fujirebio, Biokit S.A., QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sekisui Diagnostics, Sysmex Corporation, Werfen S.A.

What Are the Primary Growth Drivers in the Blood Transfusion Diagnostics Market?

The requirement for blood transfusion arises in patients who are subjected to surgical operations due to the loss of blood in the process. The role of blood transfusion diagnostics is crucial as they are utilized during the procedures for blood screening before its transfusion to the patient, thereby preventing the spread of infectious diseases. An article from the US National Library of Medicine, National Institutes of Health, mentions about 310 million surgeries being performed yearly. As a consequence of this rise in surgical procedures, the necessity for blood transfusion diagnostics is predicted to escalate.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2494&type=smp

What Are the Leading Segments in the Global Blood Transfusion Diagnostics Industry?

The blood transfusion diagnostics market covered in this report is segmented –

1) By Type: Instruments and Kits, Reagents, Other Types

2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test

3) By Application: Blood Grouping, Disease Screening

4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies

Subsegments:

1) By Instruments and Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems

2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes and Other Reagents

3) By Other Types: Software Solutions, Consumables, Training And Support Services

What Are the Key Market Trends in the Blood Transfusion Diagnostics Industry?

The escalating need for sophisticated diagnostic methods, coupled with the rising incidence of infectious diseases caused by bacteria and viruses, is fuelling the preference for nucleic acid amplification testing (NAAT/NAT). This technique enhances blood safety and efficiency while speeding up the result time. NAT effectively identifies specific nucleic acids, viruses, or bacteria that serve as pathogens in blood, tissue, or urine. It is extremely sensitive and precise in amplifying targeted viral DNA regions, thereby enabling earlier detection in comparison to other standard procedures and reducing the infectious period. For example, a licensing agreement has been established between XCRP Diagnostic Inc. and Luminex Corporations for the Xtreme Chain Reaction Nucleic Acid Amplification Technology from XCRP. This deal grants Luminex exclusive rights to incorporate XCRP’s NAAT technology into its imminent molecular diagnostic portfolio.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

What Is the Regional Outlook for the Blood Transfusion Diagnostics Market?

The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2494

This Report Delivers Insight On:

1. How big is the blood transfusion diagnostics market, and how is it changing globally?

2. Who are the major companies in the blood transfusion diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the blood transfusion diagnostics market right now?

4. Which products or customer segments are growing the most in the blood transfusion diagnostics market?

5. What factors are helping or slowing down the growth of the blood transfusion diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model